| Dr Derek Tyler Pantiel, DPM | |
|
1602 Doctors Cir, Wilmington, NC 28401-7406 | |
| (910) 343-8889 | |
| Not Available |
| Full Name | Dr Derek Tyler Pantiel |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 13 Years |
| Location | 1602 Doctors Cir, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528353638 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Columbus Regional Healthcare System | Whiteville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Instride Foot And Ankle Specialists, Pllc | 7012168271 | 55 |
News Archive
Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Sheila Arvikar, Massachusetts General Hospital, Boston, USA, will present a study titled "Inflammation in the Mouth and Joints in Rheumatoid Arthritis."
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today reported updated data from a pivotal trial of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and a phase II trial in relapsed or refractory systemic anaplastic large cell lymphoma.
Neuropathic pain - which affects more than 1 million Americans - could be reduced or even eliminated by targeting brain cells that are supposed to provide immunity but, in some instances, do the opposite, causing chronic pain that could last a lifetime.
U.S. District Judge Lee Yeakel promised to rule in the case as quickly as possible. Whichever side loses is likely to appeal.
A drug for epilepsy with a new mechanism of action is safe and effective, according to a study published in the April 10, 2007, issue of Neurology", the scientific journal of the American Academy of Neurology.
› Verified 7 days ago
| Provider Name | Instride Foot & Ankle Specialists, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457601601 PECOS PAC ID: 7012168271 Enrollment ID: O20121115000501 |
News Archive
Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Sheila Arvikar, Massachusetts General Hospital, Boston, USA, will present a study titled "Inflammation in the Mouth and Joints in Rheumatoid Arthritis."
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today reported updated data from a pivotal trial of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and a phase II trial in relapsed or refractory systemic anaplastic large cell lymphoma.
Neuropathic pain - which affects more than 1 million Americans - could be reduced or even eliminated by targeting brain cells that are supposed to provide immunity but, in some instances, do the opposite, causing chronic pain that could last a lifetime.
U.S. District Judge Lee Yeakel promised to rule in the case as quickly as possible. Whichever side loses is likely to appeal.
A drug for epilepsy with a new mechanism of action is safe and effective, according to a study published in the April 10, 2007, issue of Neurology", the scientific journal of the American Academy of Neurology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Derek Tyler Pantiel, DPM 1602 Doctors Cir, Wilmington, NC 28401-7406 Ph: (910) 343-8889 | Dr Derek Tyler Pantiel, DPM 1602 Doctors Cir, Wilmington, NC 28401-7406 Ph: (910) 343-8889 |
News Archive
Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Sheila Arvikar, Massachusetts General Hospital, Boston, USA, will present a study titled "Inflammation in the Mouth and Joints in Rheumatoid Arthritis."
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today reported updated data from a pivotal trial of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and a phase II trial in relapsed or refractory systemic anaplastic large cell lymphoma.
Neuropathic pain - which affects more than 1 million Americans - could be reduced or even eliminated by targeting brain cells that are supposed to provide immunity but, in some instances, do the opposite, causing chronic pain that could last a lifetime.
U.S. District Judge Lee Yeakel promised to rule in the case as quickly as possible. Whichever side loses is likely to appeal.
A drug for epilepsy with a new mechanism of action is safe and effective, according to a study published in the April 10, 2007, issue of Neurology", the scientific journal of the American Academy of Neurology.
› Verified 7 days ago
Richard R. Recko D.p.m., Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 1776 Wellington Ave, Suite 1, Wilmington, NC 28403 Phone: 910-762-2404 Fax: 910-762-4249 | |
Kevin Brady, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1705 Gardner Dr, Wilmington, NC 28405 Phone: 910-343-5300 Fax: 910-254-4680 | |
Dr. Edwin Britt Martin Iii, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5305 Wrightsville Ave, Bld. L, Wilmington, NC 28403 Phone: 910-681-1073 | |
John D Lanthier, Dpm, Facfas Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4121 Abbington Ter, Wilmington, NC 28403 Phone: 910-313-3366 Fax: 910-313-3377 | |
Two Step Podiatry Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4113 Oleander Dr, Suite G, Wilmington, NC 28403 Phone: 440-623-1221 | |
Coastal Carolina Foot & Ankle Associates Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1602 Doctors Cir, Wilmington, NC 28401 Phone: 910-343-8889 Fax: 910-343-9990 | |
Summit Podiatry Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4113 Oleander Dr, Suite G, Wilmington, NC 28403 Phone: 910-791-1300 Fax: 791-791-4125 |